Anti Cardiolipin IgG Test at Lahore PCR Lab

Introduction to the Anti Cardiolipin IgG Test

The Anti Cardiolipin IgG (Immunoglobulin G) test is a highly specialized serological assay designed to detect and quantify IgG autoantibodies directed against cardiolipin in the blood. Cardiolipin is an essential anionic phospholipid primarily located within the inner mitochondrial membrane of cells, playing a critical role in maintaining mitochondrial structure and cellular respiration. In certain autoimmune states, the body\’s immune system mistakenly identifies these phospholipids—often when complexed with helper proteins like beta-2 glycoprotein I—as foreign invaders, producing autoantibodies against them. The presence of these autoantibodies can significantly disrupt normal vascular endothelial function, platelet activity, and the coagulation cascade, leading to a hypercoagulable state where blood clots form too easily within blood vessels.

At Lahore PCR Lab, located in the heart of Lahore, Pakistan, this test is performed using state-of-the-art enzyme-linked immunosorbent assay (ELISA) technology. This advanced methodology allows for the precise quantification of IgG antibodies, measured in GPL units (G-phospholipid units), providing clinicians with highly reliable data to guide their diagnostic and therapeutic decisions. The evaluation of cardiolipin antibodies is of paramount clinical importance, particularly in patients presenting with unexplained arterial or venous thrombotic events, recurrent pregnancy losses, or systemic autoimmune diseases. By identifying these pathogenic antibodies, the medical team at Lahore PCR Lab helps patients and their physicians uncover the underlying cause of life-threatening clotting disorders and pregnancy complications, paving the way for targeted, life-saving interventions.

The diagnostic value of the Anti Cardiolipin IgG test lies in its high sensitivity for Antiphospholipid Syndrome (APS), also known as Hughes Syndrome. APS is a systemic autoimmune disorder characterized by recurrent vascular thrombosis and/or pregnancy morbidity associated with persistent antiphospholipid antibodies. While multiple classes of anticardiolipin antibodies exist (including IgG, IgM, and IgA), the IgG isotype is clinically recognized as the most pathogenic and is most strongly correlated with clinical manifestations such as deep vein thrombosis (DVT), pulmonary embolism, stroke, myocardial infarction, and placental insufficiency. Consequently, this test serves as a cornerstone diagnostic tool, enabling early therapeutic management, such as long-term anticoagulation or antiplatelet therapy, which dramatically reduces the risk of recurrent thrombotic events and improves gestational outcomes in pregnant women.

Clinical Procedure: What to Expect

Patient Preparation

Proper patient preparation is essential to ensure the accuracy and reliability of the Anti Cardiolipin IgG test results. While this is a standard blood test, adhering to the following guidelines helps minimize potential pre-analytical variables:

• No Strict Fasting Required: Fasting is generally not mandatory for the Anti Cardiolipin IgG test. However, patients are advised to avoid consuming excessively fatty meals for a few hours before the blood draw, as lipemic serum can sometimes interfere with optical density measurements in ELISA testing.
• Medication Disclosure: It is critical to inform your prescribing physician and the laboratory staff at Lahore PCR Lab of all medications you are currently taking. This includes oral contraceptives, hormone replacement therapy, and especially anticoagulants (such as warfarin, heparin, or direct oral anticoagulants like rivaroxaban and apixaban). While these medications do not directly alter the level of anticardiolipin antibodies, they are vital for the clinical interpretation of your overall coagulation profile.
• Hydration: Drinking an adequate amount of water before the procedure is highly recommended. Good hydration ensures that veins are well-filled and easily accessible, making the venipuncture process smoother and more comfortable.
• Wear Appropriate Clothing: Wear a loose-fitting shirt or clothing with sleeves that can be easily rolled up above the elbow, allowing the phlebotomist unobstructed access to the venipuncture site.
• Rescheduling During Acute Illness: If you are experiencing an acute viral or bacterial infection, consult your physician about whether to postpone the test. Transient anticardiolipin antibodies can temporarily appear during acute infections, potentially leading to a false-positive result that does not reflect chronic autoimmune pathology.

During the Procedure

The blood collection procedure for the Anti Cardiolipin IgG test at Lahore PCR Lab is a routine, safe, and quick process conducted by highly trained and professional phlebotomists. The entire procedure typically takes less than five minutes and follows strict hygienic and safety protocols:

• Patient Identification and Setup: The phlebotomist will first verify your identity using your registration details. You will be seated comfortably in a specialized blood collection chair.
• Vein Selection: The phlebotomist will inspect your arm, usually in the antecubital fossa (the bend of the elbow), to locate a suitable, prominent vein. A sterile tourniquet will be applied a few inches above the selected site to increase venous pressure and make the vein more visible and palpable.
• Sanitization: The skin over the selected vein is thoroughly cleansed with a 70% isopropyl alcohol swab using a circular motion from the center outward. The area is allowed to air-dry completely to prevent hemolysis of the blood sample and to minimize any stinging sensation during needle insertion.
• Venipuncture: Using a sterile, single-use, high-quality needle attached to a vacuum collection tube (typically a gold-top serum separator tube or a red-top tube), the phlebotomist will gently insert the needle into the vein. You may feel a brief, mild pinch or prick.
• Sample Collection: Blood will flow smoothly into the collection tube. Once the required volume of blood is collected, the tourniquet is released to restore normal circulation.
• Post-Puncture Care: The phlebotomist will gently withdraw the needle and immediately apply a sterile cotton ball or gauze pad to the puncture site, instructing you to apply firm pressure for a few minutes to stop any bleeding. A small adhesive bandage or medical tape will then be secured over the site.
• Sample Processing: The collected blood sample is labeled immediately at your side with your unique barcode. It is then sent to the laboratory department, where it undergoes centrifugation to separate the serum from the cellular components. The clear serum is then analyzed using advanced ELISA instruments to detect the presence and concentration of Anti Cardiolipin IgG antibodies.

When is an Anti Cardiolipin IgG Performed?

Evaluation of Unexplained Venous or Arterial Thrombosis

Physicians frequently request an Anti Cardiolipin IgG test when a patient, particularly a young individual under the age of 50, presents with an unexplained blood clot. Venous thromboses commonly manifest as deep vein thrombosis (DVT) in the lower extremities, characterized by unilateral leg swelling, warmth, redness, and pain, or as a pulmonary embolism (PE), which presents with sudden shortness of breath, chest pain, and rapid heart rate. Arterial thromboses can lead to ischemic strokes, transient ischemic attacks (TIAs), or myocardial infarctions in individuals without traditional cardiovascular risk factors like hypertension, hyperlipidemia, or diabetes. By measuring the levels of anticardiolipin IgG, clinicians can determine if an underlying autoimmune hypercoagulable state is driving these dangerous clotting events, which is essential for determining the appropriate duration and intensity of anticoagulant therapy.

Investigation of Recurrent Pregnancy Loss

Recurrent pregnancy loss is a deeply distressing clinical issue, defined as two or more consecutive spontaneous abortions. Antiphospholipid Syndrome is the most common treatable systemic autoimmune cause of recurrent pregnancy loss. The Anti Cardiolipin IgG test is indicated for women who have experienced three or more unexplained consecutive miscarriages before the 10th week of gestation, one or more unexplained deaths of a morphologically normal fetus at or beyond the 10th week of gestation, or one or more premature births of a normal neonate before the 34th week of pregnancy due to severe preeclampsia, eclampsia, or placental insufficiency. The presence of these antibodies causes thrombosis in the placental microvasculature, leading to placental infarction, restricted fetal growth, and pregnancy loss. Identifying these antibodies allows obstetricians to implement effective treatment regimens, such as low-dose aspirin and low-molecular-weight heparin, to safeguard future pregnancies.

Diagnosis of Antiphospholipid Syndrome (APS)

The definitive diagnosis of Antiphospholipid Syndrome requires a combination of clinical criteria (vascular thrombosis or pregnancy complications) and laboratory evidence. The Anti Cardiolipin IgG test is one of the three primary laboratory assays used to establish this diagnosis, alongside the Lupus Anticoagulant test and the Anti-Beta-2 Glycoprotein 1 antibody test. To meet the international consensus criteria (Sapporo/Sydney criteria) for APS, a patient must test positive for anticardiolipin IgG (or other antiphospholipid antibodies) on two or more occasions at least 12 weeks apart. This repeat testing is crucial to rule out transient antibody production caused by temporary infections or drug exposures. Lahore PCR Lab provides precise, reproducible quantitative measurements that are vital for clinicians to confirm or rule out a diagnosis of primary or secondary APS.

Monitoring Systemic Lupus Erythematosus (SLE) and Autoimmune Disorders

Patients diagnosed with systemic lupus erythematosus (SLE) or other connective tissue diseases (such as rheumatoid arthritis, Sjögren\’s syndrome, or systemic sclerosis) are at a significantly higher risk of developing secondary Antiphospholipid Syndrome. Approximately 30% to 40% of patients with SLE test positive for antiphospholipid antibodies. Clinicians routinely order the Anti Cardiolipin IgG test for these patients to assess their risk profile for thrombotic complications. Knowing that an SLE patient is positive for anticardiolipin IgG allows rheumatologists to adopt a more vigilant preventive strategy, closely monitoring the patient during high-risk periods such as surgeries, prolonged immobilization, or pregnancy, and potentially initiating prophylactic antiplatelet therapy to prevent the onset of clinical thrombosis.

Investigation of Unexplained Thrombocytopenia or Prolonged Clotting Times

Unexplained thrombocytopenia (a persistently low blood platelet count) is a common hematological manifestation of Antiphospholipid Syndrome, often occurring because anticardiolipin antibodies bind to and activate platelets, leading to their premature clearance from the circulation. Additionally, during routine coagulation screening, some patients may exhibit an unexplained prolongation of the Activated Partial Thromboplastin Time (aPTT). While a prolonged aPTT typically suggests a bleeding tendency, in patients with antiphospholipid antibodies, it paradoxically indicates an increased risk of clotting due to the in vitro interference of these antibodies with phospholipid reagents. When faced with unexplained thrombocytopenia or an isolated prolonged aPTT, hematologists order the Anti Cardiolipin IgG test to investigate whether an autoimmune-mediated mechanism is responsible.

What Does an Anti Cardiolipin IgG Detect?

The Anti Cardiolipin IgG test is designed to detect and quantify specific autoantibodies in the blood. A positive result or specific levels of these antibodies can indicate several clinical findings and underlying pathological processes, including:

• Elevated IgG Antibody Titers: Indicates an active, autoimmune-mediated production of antibodies targeting cardiolipin-protein complexes.
• Primary Antiphospholipid Syndrome (APS): Confirms the presence of the primary autoimmune disorder when clinical criteria are met in the absence of other connective tissue diseases.
• Secondary Antiphospholipid Syndrome: Detects the presence of APS occurring secondary to systemic lupus erythematosus (SLE) or other autoimmune conditions.
• High Risk of Deep Vein Thrombosis (DVT): Associated with a significantly increased propensity for clot formation in the deep veins of the legs.
• Predisposition to Pulmonary Embolism (PE): Indicates a risk of venous clots breaking free and traveling to the lungs, causing life-threatening arterial blockage.
• Arterial Thrombosis Risk: Signals a heightened risk of clot formation in major arteries, which can lead to tissue ischemia and organ damage.
• Increased Risk of Ischemic Stroke: Associated with cerebrovascular accidents caused by arterial occlusion in the brain, particularly in younger patients.
• Transient Ischemic Attacks (TIAs): Detects a potential underlying cause for recurrent, temporary neurological deficits or “mini-strokes.”
• Myocardial Infarction Risk: Indicates an autoimmune risk factor for premature heart attacks due to coronary artery thrombosis.
• Placental Insufficiency: Reflects compromised blood flow through the placenta, which can severely restrict fetal oxygen and nutrient supply.
• Intrauterine Growth Restriction (IUGR): Associated with poor fetal growth in utero due to microvascular thrombosis in the placental bed.
• Early Pregnancy Loss: Detects a major immunological cause of recurrent spontaneous abortions occurring before the 10th week of gestation.
• Late-Term Fetal Demise: Associated with unexplained stillbirth or fetal death after the 10th week of pregnancy.
• Severe Early-Onset Preeclampsia: Indicates a risk of developing dangerously high blood pressure and proteinuria during pregnancy before 34 weeks of gestation.
• Autoimmune Thrombocytopenia: Explains a low platelet count resulting from antibody-mediated platelet activation and subsequent destruction.
• Livedo Reticularis: Associated with a mottled, purplish, lace-like discoloration of the skin caused by microvascular thrombosis in dermal vessels.
• Neurological Manifestations: Can be linked to non-stroke neurological symptoms such as chorea, transverse myelitis, migraine headaches, or cognitive decline.
• Cardiac Valvular Disease: Associated with thickening or sterile vegetations on heart valves (Libman-Sacks endocarditis), particularly the mitral valve.
• Renal Microangiopathy: Indicates a risk of small blood vessel clots within the kidneys, potentially leading to hypertension and renal impairment.
• Transient Positivity due to Viral Infections: Detects temporary antibody elevations caused by acute infections like Hepatitis C, HIV, Cytomegalovirus (CMV), or Epstein-Barr Virus (EBV).
• Transient Positivity due to Bacterial Infections: May show temporary positive results associated with syphilis, tuberculosis, or infective endocarditis.
• Drug-Induced Antibodies: Identifies potential antibody production triggered by medications such as chlorpromazine, procainamide, quinidine, or phenytoin.
• Persistent Autoimmune Response: Confirmed when high levels of IgG remain elevated upon retesting after a 12-week interval.
• Co-positivity with Anti-Beta-2 Glycoprotein 1: Indicates a broader spectrum of antiphospholipid antibodies, increasing the clinical specificity for APS.
• Triple Positivity: Identifies the highest-risk profile when positive alongside Lupus Anticoagulant and Anti-Beta-2 Glycoprotein 1, correlating with the highest rate of thrombotic recurrence.

Turnaround Time and Report Access at Lahore PCR Lab

At Lahore PCR Lab, we understand that waiting for diagnostic test results can be an anxious time for patients and their families. Therefore, we are committed to providing rapid, accurate, and highly reliable reporting. The Anti Cardiolipin IgG test is processed using advanced automated ELISA platforms that undergo rigorous daily calibration and quality control checks. Under standard operating procedures, the turnaround time for this specialized immunological assay is typically within 24 to 48 hours from the time of sample collection.

Once the analysis is complete, the raw data is reviewed and verified by our team of experienced consultant pathologists to ensure clinical accuracy. As soon as the report is finalized, patients receive an automated SMS notification on their registered mobile number. Lahore PCR Lab offers multiple convenient ways to access your diagnostic reports. Patients can download their reports directly from our secure online portal by entering their lab ID and password. Alternatively, printed reports can be collected from our main facility in Lahore or any of our designated collection centers. We also offer the option to receive reports directly via email, ensuring that you and your consulting physician can access these critical results without delay to make timely clinical decisions.

Anti Cardiolipin IgG Findings Overview

The following table provides a general overview of the parameters evaluated during an Anti Cardiolipin IgG test, along with typical normal and abnormal clinical findings:

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Anti-Cardiolipin IgG Antibody Level	Negative (<15 GPL units)	Positive (>15 GPL units), categorized as low, medium, or high positive titers.
Venous Thrombosis Risk Assessment	Low / Baseline risk	High risk of developing Deep Vein Thrombosis (DVT) or Pulmonary Embolism (PE).
Arterial Thrombosis Risk Assessment	Low / Baseline risk	Increased risk of ischemic stroke, transient ischemic attacks (TIAs), or myocardial infarction.
Pregnancy Outcome Correlation	Normal gestation, healthy term delivery	Recurrent early miscarriages, late fetal demise, severe preeclampsia, or placental insufficiency.
Platelet Count (Associated)	Normal range (150,000 – 450,000/µL)	Thrombocytopenia (low platelet count) due to antibody-mediated clearance.
Coagulation Profile (aPTT)	Normal clotting time (typically 25-35 seconds)	Paradoxically prolonged aPTT that does not correct with normal plasma mixing studies.
Clinical Classification	No evidence of Antiphospholipid Syndrome	Primary or Secondary Antiphospholipid Syndrome (APS) if persistent over 12 weeks.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient\’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Lahore PCR Lab for Anti Cardiolipin IgG?

When it comes to specialized immunological testing, choosing a reliable diagnostic partner is essential. Lahore PCR Lab is a trusted name in Lahore, Pakistan, offering several key advantages:

• Experienced Healthcare Professionals: Our laboratory is staffed by highly qualified consultant pathologists and technologists specializing in molecular diagnostics and immunology.
• Patient-Focused Care: We prioritize patient comfort and convenience, ensuring a compassionate and professional environment during blood collection.
• Quality Diagnostic Services: We utilize state-of-the-art automated ELISA systems and adhere to strict international quality control standards.
• Professional Reporting: Our reports are detailed, clear, and structured to provide maximum clinical utility to your consulting physician.
• Modern Diagnostic Approach: We continuously update our testing methodologies and equipment to align with global diagnostic advancements.
• Comfortable Environment: Our collection centers in Lahore are designed to be clean, hygienic, and welcoming for all patients.
• Convenient Location: Easily accessible locations across Lahore make it simple for patients to visit for sample collection.
• Commitment to Accurate Diagnosis: We understand the critical nature of autoimmune testing and are dedicated to delivering results you can trust for clinical decision-making.